Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Epileptiform discharges are associated with increased theta activity over time in patients with Lewy body dementia.

Neuroscience·2026
Same author

Morbidity and medication use preceding a diagnosis of late-onset Alzheimer's disease: a Danish nationwide study.

Journal of neurology·2026
Same author

Associations between a psychosocial intervention and quality of life and caregiver-related outcomes in family caregivers of people with dementia: the Danish DemTool trial.

BMC geriatrics·2026
Same author

Obstructive apneas immediately impact atrial hemodynamics and arrhythmias.

Heart rhythm·2026
Same author

Plasma phosphorylated tau217 discordance with amyloid status in an ethnically diverse mixed memory clinic cohort.

Journal of the neurological sciences·2026
Same author

Epileptiform discharges in neurodegenerative diseases linked to atrophy but not associated with iron depositions.

GeroScience·2026
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Mathias Holsey Gramkow1, Frederikke Kragh Clemmensen1, Andreas Brink-Kjær2,3

  • 1Danish Dementia Research Centre, Dept. of Neurology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

动态的瞳孔变化和夜间活动减少是阿尔茨海默病 (AD) 进展的有希望的数字生物标志物. 这些措施,从定量光反射瞳孔测量 (qLRP) 和动图,可以帮助早期AD预后和疾病跟踪.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物 生物标志物
  • 老年学是一门学科.

背景情况:

  • 阿尔茨海默病 (AD) 需要可访问的预后生物标志物来进行疾病修饰疗法.
  • 定量光反射瞳孔测量 (qLRP) 和动图分别评估中脑功能和昼夜活动,两者都在AD中发生变化.
  • 这项研究研究了qLRP和AD早期的动图的预后和疾病跟踪能力.

研究的目的:

  • 确定qLRP和早期阿尔茨海默病中的动图的预后和疾病跟踪能力.
  • 评估瞳孔和活动测量与临床,认知和神经成像进展的关联.
  • 评估这些数字生物标志物用于AD预后和疾病监测.

主要方法:

  • 一个单一中心的纵向队列研究包括86名阿尔茨海默病患者用于qLRP和58名用于动图,并进行了18-24个月的跟踪.
  • 在基线和随访时进行了qLRP和动图;在1年随访时评估了临床进展,神经成像和认知衰退 (MMSE).
  • 使用后勤回归和重复测量相关性来分析生物标志物与疾病进展之间的关联.

主要成果:

  • 静止瞳孔直径的减少与更高的临床进展风险和认知衰退相关.
  • 基线的瞳孔变化预测了神经成像进展.
  • 减少夜间活动和每日内步骤的变化预测了临床进展和认知衰退.

结论:

  • 动态的瞳孔变化和夜间活动减少是AD的有价值的数字生物标志物.
  • 这些措施反映了兴奋状态和疾病进展的变化.
  • qLRP和动图显示在缓解AD预后和疾病跟踪方面具有实用性.